Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04010045 · ClinicalTrials.gov registry record
REvascularization RateS and Clinical OUtcomes With DABRA Laser. A Long-Term 2-year Study
A clinical trial, sponsored by Ra Medical Systems.
- Terminated
- Registry status
- 19
- Enrollment target
NCT04010045 is a clinical trial that was terminated before completion, run by Ra Medical Systems. The registered enrollment target is 19 participants.
The verdict
NCT04010045 was terminated before completion, sponsored by Ra Medical Systems.
- TERMINATED
- Registry status
- 19 participants
- Enrollment target
Study Summary
This is an observational study of the DABRA Laser System and other medical devices intended for endovascular treatment of peripheral artery disease.
Interventions
- DEVICE Endovascular Treatment of PAD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 19 participants |
| Start Date | 2019-05-02 |
| Est. Completion | 2020-10-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04010045
The ClinicalTrials.gov registry entry for NCT04010045 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 19 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ra Medical Systems, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Endovascular Treatment of PAD is the first listed.
NCT04010045 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04010045 about?
NCT04010045 is a clinical study titled "REvascularization RateS and Clinical OUtcomes With DABRA Laser. A Long-Term 2-year Study". This is an observational study of the DABRA Laser System and other medical devices intended for endovascular treatment of peripheral artery disease.
What is the current status of trial NCT04010045?
This trial is currently terminated. The enrollment target is 19 participants. The study started on 2019-05-02. Estimated completion is 2020-10-15.
What interventions are being tested in trial NCT04010045?
The interventions under investigation include: Endovascular Treatment of PAD (DEVICE).
Who is sponsoring clinical trial NCT04010045?
This trial is sponsored by Ra Medical Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.